Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The median citation count of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Osteomyelitis in complicated bones: the role of FDG PET/CT18
Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma14
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study14
Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability12
Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?12
Targeted alpha therapy in prostate cancer: review of available agents in clinical practice12
Pediatric nuclear medicine: continuing the evolution11
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study9
Combination prostate-specific membrane antigen-targeted radiopharmaceutical therapy in metastatic prostate cancer9
The value of artificial intelligence in PSMA PET: a pathway to improved efficiency and results8
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus8
Hybrid positron emission tomography/magnetic resonance imaging in musculoskeletal conditions: be hybrid!8
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response7
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?7
Theragnostics before we found its name6
[18F]FDG and [68Ga]Ga-PSMA dual-tracer total-body PET/CT and PET/MR in patients with prostate cancer6
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans6
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicity6
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer5
Radiation protection aspects for alpha therapies5
FDG PET/CT in vascular graft infection: a pictorial review5
Perceptual omission errors in positron emission tomography and computed tomography reporting4
Technical concepts on blood pool phase SPECT (acquisition, reconstruction)4
Challenges in theragnostics4
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review4
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership4
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma4
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers4
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging4
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction3
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis3
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors3
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study3
Side effects of theragnostic agents currently employed in clinical practice3
Fever of unknown origin in pediatrics: role of nuclear medicine3
Theragnostics applications and challenges3
18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection2
Next-level precision medicine: why the theragnostic approach is the future2
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center2
Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls2
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment2
Emerging topics in neuroimaging2
[18F]FDG PET/CT for the diagnosis of diabetic foot osteomyelitis2
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study2
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism2
FDG PET/CT for imaging of infection and inflammation: a practical approach2
Total variation regularized expectation maximization reconstruction improves 68Ga-FAPI-04 PET/CT image quality as compared to ordered subset expectation maximization reconstruction2
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases2
Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF- versus non-TOF-PET/MRI: a pilot study2
Radiosynoviorthesis: almost seventy years of experience but still somewhat fameless2
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism2
Predictive value of 18F-fluorodeoxyglucose PET/CT in histological grade of incidental colorectal adenoma2
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma2
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data2
Local treatment of synovitis2
Fully integrated [18F]FDG PET/MR in large vessel vasculitis1
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization1
Hepatobiliary imaging: advancing precision diagnosis and therapy of hepatobiliary disease through advanced imaging and locoregional therapies1
PET imaging and radionuclide therapy in neuroendocrine prostate cancer: a systematic review1
Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors1
Integration of molecular imaging in the personalized approach of patients with adrenal masses1
The value of radiosynoviorthesis for treatment of chronic synovitis in hemophilic joint disease1
Assessment of the interobserver and the intraobserver reproducibility for the detection of renal cortical defects in adults and children using [99mTc]Tc-MAG31
Contribution of positron emission tomography/magnetic resonance imaging in musculoskeletal malignancies1
Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior1
Blood pool phase SPECT: the missing link of bone scintigraphy1
Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score1
A review of F-18 fluorodeoxyglucose PET/CT in the evaluation and treatment of hepatobiliary tumors1
Impact of pre-scan patient-related factors on diagnostic yield of 18F FDG PET/CT in fever of unknown origin1
Parathyroid imaging1
A retrospective study with long term follow-up of Graves' disease patients treated with low activities of 131Iodine1
The role of BRAF V600E mutation in post-surgical 131I therapy in papillary thyroid carcinoma: a study based on SPECT-CT uptake analysis1
Risk factors for rib metastases of lung cancer patients with high-uptake rib foci on 99Tcm-MDP SPECT/CT1
[18F]FDG PET/CT in cardiovascular infections: a practical approach1
Changes over the years in radiopharmaceutical design1
Diagnostic yield and impact on patient management from [18F]FDG-PET/CT in FUO/IUO in the adult population1
Current approach to pediatric differentiated thyroid cancer1
Navigating the prostate cancer frontiers: charting new horizons in molecular imaging and targeted radionuclide therapy1
Long-term clinical results from 10 years follow-up after radiosynoviorthesis: a prospective observational study1
Theragnostic in neuroendocrine tumors1
Incidence of subclinical and overt hypothyroidism in children treated with [131I]mIBG: a systematic review and meta-analysis1
PET/MRI evaluation of hepatobiliary tumors1
Update on FDG-PET in pediatric lymphoma1
Uptake pattern of [68Ga]Ga-DOTA-NOC in tissues: implications for inflammatory diseases1
An essential practice summary of the new EANM guidelines for parathyroid imaging1
Positron emission tomography/magnetic resonance imaging in musculoskeletal benign conditions1
0.13628196716309